6th Annual RAS-Targeted Drug Development Summit
Evvnt Promotion / evvnt
Archiv
24.09.2024 - 26.09.2024 Hilton Boston Park Plaza, 50 Park Plaza, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:45 PM
Kongressthemen
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance.
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance.
Kongressorganizer (PCO)
Hanson Wade Group
Hanson Wade Group
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2464057-3?pid=4832
Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, and more
URL:
Brochure: https://go.evvnt.com/2464057-3?pid=4832
Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2464057-2?pid=4832
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
